- Home
- PNFP vs AXSM Comparison
PNFP vs AXSM Comparison
Compare PNFP & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PNFP | AXSM |
|---|---|---|
| Founded | 2000 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 5.9B |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | PNFP | AXSM |
|---|---|---|
| Price | $99.85 | $148.15 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 15 | 20 |
| Target Price | $112.29 | ★ $176.00 |
| AVG Volume (30 Days) | ★ 923.3K | 526.6K |
| Earning Date | 01-20-2026 | 11-03-2025 |
| Dividend Yield | ★ 0.96% | N/A |
| EPS Growth | ★ 49.26 | N/A |
| EPS | ★ 7.83 | N/A |
| Revenue | ★ $1,885,186,000.00 | $561,263,000.00 |
| Revenue This Year | $31.05 | $66.20 |
| Revenue Next Year | $121.72 | $57.56 |
| P/E Ratio | $12.76 | ★ N/A |
| Revenue Growth | 21.58 | ★ 65.83 |
| 52 Week Low | $81.57 | $75.56 |
| 52 Week High | $127.85 | $152.94 |
Technical Indicators
Market Signals| Indicator | PNFP | AXSM |
|---|---|---|
| Relative Strength Index (RSI) | 71.00 | 56.94 |
| Support Level | $92.53 | $144.00 |
| Resistance Level | $102.24 | $150.00 |
| Average True Range (ATR) | 2.05 | 4.15 |
| MACD | 0.90 | -0.73 |
| Stochastic Oscillator | 81.33 | 57.42 |
Price Performance
Historical ComparisonAbout PNFP Pinnacle Financial Partners Inc.
Pinnacle Financial Partners Inc is a financial holding company. The company operates through its wholly-owned subsidiary, Pinnacle Bank. The bank provides a full range of lending products, including commercial, real estate, and consumer loans to individuals and small to medium-sized businesses. It operates as a community bank mainly in the urban markets of Nashville, Knoxville, Memphis, and Chattanooga, Tennessee, as well as surrounding counties. It relies heavily on mergers and acquisitions. A majority of its loan portfolio is in commercial loans, mainly real estate, as well as industrial loans. The bank generates a majority of its net revenue through net interest income.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.